neurfilamenT foR diffErEntiaTion Of Pseudo-relapse

neurfilamenT foR diffErEntiaTion Of Pseudo-relapse - TREETOP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030784

Enrollment

150

Registered

2022-11-21

Start date

2022-11-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G35.1

Interventions

Group 1: RRMS patients undergo the following interventions/examinations: - Blood sampling (during inpatient stay, routine check-ups if applicable). - Telephone interview 90 days after any relapse even

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. RRMS with subjective disease activity. 2. capable of consent. 3. Over 18 years old

Exclusion criteria

Exclusion criteria: 1. No consent. 2. No RRMS, 3. <18 years old.

Design outcomes

Primary

Measure	Time frame
Serum Neurofilament concentrations at acute event and EDSS/progression 90d later.	—

Secondary

Measure	Time frame
Stratification possibility of NFL with regard to course and affected functional system.	—

Countries

Germany

Contacts

Public ContactFalk Steffen

Universitätsmedizin Mainz Klinik und Poliklinik für Neurologie

falk.steffen@unimedizin-mainz.de06131177156

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026